Delivery Order SPE2DB20D3103-SPE2DB25FM5L2

Award Date 1/31/25
Potential Completion Date 2/3/25
Potential Value $8.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,363.76 firm fixed-price delivery order is for the supply of 4567274510 - Methylene Blue 50 mg/10 ml vials, with a performance period through February 18, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award, with ID SPE2DX15D6044|SPE2DX24FCRCR, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,021.06 firm-fixed-price delivery order is for 4564441645 METHYLENE BLUE 50 MG/10ML VIAL 10ML. The contract has no set-aside designation, indicating open competition. It is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc.,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,253.68 firm fixed-price delivery order is for the supply of 4566243396 - Methylene Blue 50 mg/10 mL vial, 10 mL. The award has an ultimate completion date of October 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,043.74 Firm Fixed Price delivery order is for the supply of 4564854478 METHYLENE BLUE 50 MG/10ML VIAL 10ML. The contract has a completion date of June 11, 2024 and does not utilize any set-aside requirements. Amerisourcebergen maintains a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, with ID SPE2DX15D2223|SPE2DX25F4GKE, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,522.52 firm fixed-price delivery order is for the supply of 4567361785 METHYLENE BLUE 50 MG/10ML VIAL 10ML. The contract has an ultimate completion date of February 25, 2025 and was awarded on February 24, 2025. Amerisourcebergen Drug Corp, the prime...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of methylene blue injection. The $1,915.58 contract has a completion date of February 2, 2024 and was awarded on December 22, 2023. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations noted. This delivery order is likely part of a larger indefinite delivery...
The Defense Logistics Agency awarded a $425,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 4561534438 Methylene Blue 1% vials. As part of its pharmaceutical supply chain management responsibilities, DLA issued this order under an existing Prime Vendor contract vehicle to fulfill medical material requirements. No subcontractors or set aside designations were identified. DLA supports all branches of the U.S. military through its worldwide logistics...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Isosulfan Blue 1% Vial, 5 mL. The contract has a firm fixed price of $21,632.21 and a period of performance through May 17, 2024. Amerisourcebergen is the prime contractor, and the contract was not set aside for any specific business type. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $42,502.14 firm fixed-price delivery order is for the supply of ISOSULFAN BLUE 1% VIAL 5ML, with a completion date of August 7, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,770.32, is for the delivery of Isosulfan Blue 1% Vial 5ML, a medical product used in healthcare settings. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FM5L2
    Delivery Order

This is a $8,628.80 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4567117601 - Methylene Blue 50 mg/10 ml vial, 10 ml, with a period of performance through February 3, 2025.

The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/2/25, 10:06 AM